The mixed analyst ratings suggest uncertainty in the market's perception of Celldex's future performance. The slight increase in the average price target indicates some positive sentiment, but the company's profitability challenges, as evidenced by a negative net margin, may offset this. The strong revenue growth is a positive indicator, but the overall impact on the stock price in the short term is likely neutral due to these mixed factors.